Head Injury in Sport
BMJ 308:1620-1624, McLatchie,G.&Jennett,B., 1994
Hearing Aids and Cochlear Implants in the Prevention of Cognitive Decline and Dementia-Breaking Through the Silence
JAMA Neurol 80:127-128, Denham,M.W.,et al, 2023
Monkeypox-Associated Central Nervous System Disease:A Case Series and Review
Ann Neurol 93:893-905, Money,K.M.,et al, 2023
Sport Associated Dementia
BMJ 372:N168, Stewart, W., 2021
Congenital Cytomegalovirus Infection
BMJ 373:m1212, Pesch, M.H.,et al, 2021
Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
Spontaneous Subarachnoid Haemorrhage
Lancet 389:655-666, Macdonald, R.L. & Schweizer, T.A., 2017
Intervention Versus Aggressive Medical Therapy for Cognition in Severe Asymptomatic Carotid Stenosis
AJNR 37:1889-1897, Lin, C.J.,et al, 2016
Neonatal Abstinence Syndrome
NEJM 375:2468-2479, McQueen, K. & Murphy-Oikonen, J., 2016
Serotonin Syndrome
BMJ 348:g1626, Buckley, N.A.,et al, 2014
Intracranial Atherosclerosis
Lancet 383:984-998, Qureshi, A. & Caplan, L.R., 2014
The Acquired Metabolic Disorders of the Nervous System, High-Altitude (mountain) sickness
Adams & Victors Principles of Neurology Chp 40, pg 1139, Ropper, A.H.,et al, 2014
The Acquired Metabolic Disorders of the Nervous System, Cretinism and Neonatal Myxedema
Adams & Victors Principles of Neurology Chp 40, pg 1156, Ropper, A.H.,et al, 2014
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Lead
Adams & Victors Principles of Neurology Chp 43, pg 1220, Ropper, A.H.,et al, 2014
Bilirubin-Induced Neurologic Damage - Mechanisms and Management Approaches
NEJM 369:2021-2030, Watchko, J.F.,et al, 2013
Cerebral Amyloid Angiopathy
eMedicine, Jan, Menon, R.S., 2012
Sporadic Cerebral Amyloid Angiopathy Revisited: Recent Insights Into Pathophysiology and Clinical Spectrum
JNNP 83:124-137, Charidimou,A.,et al, 2012
Pediatric Neurological Complications of 2009 Pandemic Influenza A (H1N1)
Arch Neurol 68:455-462, Kedia, S.,et al, 2011
Risk of Dementia and AD with Prior Exposure to NSAIDs in an Elderly Community-Based Cohort
Neurol 72:1899-1905,1884, Breitner,J.C.S.,et al, 2009
Changes in the Incidence and Predictors of Human Immunodeficiency Virus-Associated Dementia in the Era of Highly Active Antiretroviral Therapy
Ann Neurol 63:213-221, Bhaskaran,K.,et al, 2008
Safety and Efficacy of Galantamine in Subjects with Mild Cognitive Impairment
Neurol 70:2024-2035, Winblad,B.,et al, 2008
A Randomized Placebo-Controlled Trial of Ginkgo Biloba for the Prevention of Cognitive Decline
Neurol 70:1807-1817,1730, Dodge,H.H.,et al, 2008
Stroke and Multi-Infarct Dementia as Presenting Symptoms of Giant Cell Arteritis: Report of 7 Cases and Review of the Literature
Medicine 87:335-344, Solans-Laque,R.,et al, 2008
Low Dose Aspirin and Cognitive Function in the Womens Health Study Cognitive Cohort
BMJ 334:987-990,961, Kang,J.H.,et al, 2007
The Neuroprotective Effects of Caffeine: A Prospective Population Study (the Three City Study)
Neurol 69:536-545, Ritchie,K.,et al, 2007
Disease-Modifying Therapies for Alzheimer Disease: Challenges to Early Intervention
Neurol 69:1622-1634, Cummings,J.L.,et al, 2007
Delirium in Older Persons
NEJM 354:1157-1165, Inouye,S.K., 2006
Developmental Neurotoxivity of Industrial Chemicals
Lancet 368:2167-2178, Grandjean,P. &Landrigan,P.J., 2006
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
NEJM 352:2379-2388,2439, Petersen,R.C.,et al, 2005
Rabies Encephalomyelitis
Arch Neurol 62:873-882,855, Burton,E.C.,et al, 2005
Statin Use and the Risk of Incident Dementia
Arch Neurol 62:1047-1051, Rea,T.D.,et al, 2005
Follow-Up of 89 Asymptomatic Patients with Adrenoleukodystrophy Treated with Lorenzos Oil
Arch Neurol 62:1073-1080,1045, Moser,H.W.,et al, 2005
Lipid Lowering Agents Are Associated With a Slower Cognitive Decline in Alzheimers Disease
JNNP 76:1624-1629, Masse,I.,et al, 2005
Adrenoleukodystrophy
JAMA 294:3131-3134, Moser,H.W.,et al, 2005
Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women
JAMA 291:2947-2958,3005, Shumaker,S.A.,et al, 2004
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
JAMA 289:2651-2662,2717, Shumaker,S.A.,et al, 2003
Leisure Activities and the Risk of Dementia in the Elderly
NEJM 348:2508-2516, Verghese,J.,et al, 2003
Encephalitis Complicating Smallpox Vaccination
Arch Neurol 60:925-928, Miravalle,A. &Roos,K.L., 2003
Reduced Incidence of AD with NSAID But Not H2 Receptor Antagonists
Neurol 59:880-886, Zandi,P.P.,et al, 2002
Abnormality of Gait as a Predictor of Non-Alzheimer's Dementia
NEJM 347:1761-1768, Verghese,J.,et al, 2002
Rectal Diazepam Gel for Treatment of Acute Repetitive Seizures in Adults
Arch Neurol 59:1915-1920, Cereghino,J.J.,et al, 2002
HIV-associated Neurologic Disease Incidence Changes: Multicenter AIDS Cohort Study, 1990-1998
Neurol 56:257-260, Sacktor,N.,et al, 2001
Hormone Replacement Therapy and Cognition
JAMA 285:1489-1499, LeBlanc,E.S.,et al, 2001
Preventable Deaths and Injuries during Magnetic Resonance Imaging
NEJM 345:1000-1001, Landrigan,C., 2001
Hormone Replacement Therapy and Reduced Cognitive Decline in Older Women
Neurol 57:2210-2216, Carlson,M.C.,et al, 2001
Reduced Prevalence of AD in Users of NSAIDs and H2 Receptor Antagonists
Neurol 54:2066-2071, Anthony,J.C.,et al, 2000
Incidence and Prevalence of Neurological Disorders Associated with HIV Since the Introduction of Highly Active Antiretroviral Therapy (HAART)
JNNP 69:376-380, Maschke,M. et al, 2000
Statins and the Risk of Dementia
Lancet 356:1627-1631, Jick,H.,et al, 2000
High Monounsaturated Fatty Acids Intake Protects Against Age-Related Cognitive Decline
Neurol 52:1563-1569, Solfrizzi,V.,et al, 1999